{"id":354055,"date":"2025-08-28T10:36:40","date_gmt":"2025-08-28T10:36:40","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-rxsight\/"},"modified":"2025-08-28T10:36:40","modified_gmt":"2025-08-28T10:36:40","slug":"how-to-buy-rxsight","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/","title":{"rendered":"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354055","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r - RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r - RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"RxSight, Inc. (RXST) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. 2025 i\u00e7in g\u00fcncel fiyat trendlerini, risk de\u011ferlendirmesini ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"RxSight, Inc. (RXST) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. 2025 i\u00e7in g\u00fcncel fiyat trendlerini, risk de\u011ferlendirmesini ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin."},"intro":"\u0130leri teknoloji t\u0131bbi teknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? RxSight, Inc. (RXST), h\u0131zla b\u00fcy\u00fcyen katarakt cerrahisi pazar\u0131nda benzersiz bir f\u0131rsat sunuyor. Bu yenilik\u00e7i \u015firket, devrim niteli\u011findeki ayarlanabilir lens teknolojisiyle g\u00f6rme d\u00fczeltmeyi de\u011fi\u015ftirdi\u2014ancak son zorluklar, piyasa volatilitesinde gezinmeyi \u00f6\u011frenen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in ilgin\u00e7 bir vaka \u00e7al\u0131\u015fmas\u0131 olu\u015fturuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130leri teknoloji t\u0131bbi teknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? RxSight, Inc. (RXST), h\u0131zla b\u00fcy\u00fcyen katarakt cerrahisi pazar\u0131nda benzersiz bir f\u0131rsat sunuyor. Bu yenilik\u00e7i \u015firket, devrim niteli\u011findeki ayarlanabilir lens teknolojisiyle g\u00f6rme d\u00fczeltmeyi de\u011fi\u015ftirdi\u2014ancak son zorluklar, piyasa volatilitesinde gezinmeyi \u00f6\u011frenen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in ilgin\u00e7 bir vaka \u00e7al\u0131\u015fmas\u0131 olu\u015fturuyor."},"body_html":"<h2>\ud83d\udcc8 RxSight Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla, RxSight, Inc. (RXST) NASDAQ borsas\u0131nda <strong>8,61 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Bu fiyat, y\u0131l\u0131n ba\u015f\u0131ndan bu yana dramatik bir d\u00fc\u015f\u00fc\u015f\u00fc temsil ediyor ve bu durum hem riskler hem de f\u0131rsatlar yarat\u0131yor.<\/p> <p><strong>Takviminize Not Edin: 6 Kas\u0131m 2025<\/strong>, RXST yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in son derece \u00f6nemli bir tarih. \u015eirketin bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 bu tarih, son d\u00f6nem performans g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 RXST Hissesini Nas\u0131l Etkiledi<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>7 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>7,95 $<\/td><td>-%37,8 (y\u0131k\u0131c\u0131 rehberlik kesintisi)<\/td><\/tr> <tr><td>8 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>35,20 $<\/td><td>+%3,2 (beklentileri a\u015ft\u0131)<\/td><\/tr> <tr><td>27 \u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>32,80 $<\/td><td>+%7,3 (g\u00fc\u00e7l\u00fc g\u00f6r\u00fcn\u00fcm)<\/td><\/tr> <tr><td>7 Kas 2024<\/td><td>\u00dcr\u00fcn G\u00fcncellemesi<\/td><td>30,10 $<\/td><td>+%5,1 (pozitif benimseme haberi)<\/td><\/tr> <tr><td>8 A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>28,50 $<\/td><td>-%4,2 (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td><\/tr> <tr><td>9 May 2024<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>29,80 $<\/td><td>+%6,8 (g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Analizi<\/strong>: RxSight hissesi kazan\u00e7lar etraf\u0131nda a\u015f\u0131r\u0131 volatilite ya\u015fad\u0131; Temmuz 2025 \u00e7\u00f6k\u00fc\u015f\u00fc en \u015fiddetli tepkiyi temsil ediyor. Pozitif s\u00fcrprizler genellikle %5-7 kazan\u00e7 getirirken, olumsuz rehberlik kesintileri %30 veya daha fazla y\u0131k\u0131c\u0131 d\u00fc\u015f\u00fc\u015flere neden olabiliyor.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2> <p>RxSight hisseleri, t\u0131bbi teknoloji sekt\u00f6r\u00fcnde en dramatik \u00e7\u00f6k\u00fc\u015flerden birini ya\u015fad\u0131 ve bu d\u00f6nemde <strong>%75'ten fazla<\/strong> de\u011fer kaybetti:<\/p> <p><strong>\u015eubat<\/strong>: 35,20 $ (y\u0131la g\u00fc\u00e7l\u00fc ba\u015flang\u0131\u00e7)<br\/> <strong>Nisan<\/strong>: 32,50 $ (erken endi\u015feler ortaya \u00e7\u0131k\u0131yor)<br\/> <strong>Haziran<\/strong>: 28,80 $ (artan yat\u0131r\u0131mc\u0131 kayg\u0131s\u0131)<br\/> <strong>Temmuz<\/strong>: 7,95 $ (rehberlik kesintisi sonras\u0131 y\u0131k\u0131c\u0131 \u00e7\u00f6k\u00fc\u015f)<br\/> <strong>A\u011fustos<\/strong>: 8,61 $ (\u0131l\u0131ml\u0131 stabilizasyon)<\/p> <p>Bu y\u0131k\u0131c\u0131 d\u00fc\u015f\u00fc\u015f, RXST'nin Ocak 2025'te hisse ba\u015f\u0131na 35 $ \u00fczerinde i\u015flem g\u00f6rd\u00fc\u011f\u00fc g\u00fc\u00e7l\u00fc bir konumdan ba\u015flad\u0131; bu, 2024'te premium katarakt intraok\u00fcler lenslerdeki g\u00fc\u00e7l\u00fc performansla destekleniyordu. Ancak, 9 Temmuz 2025'te y\u00f6netimin tam y\u0131l gelir rehberli\u011fini kesmesi ve hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratan 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klamas\u0131yla hisseler g\u00fcn i\u00e7inde neredeyse <strong>%50<\/strong> \u00e7\u00f6k\u00fc\u015f ya\u015fad\u0131.<\/p>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p><strong>2025 Y\u0131l Sonu<\/strong>: 8,00-10,00 $ \u2192 <strong>TUT<\/strong><br\/> Analistler, 11 firma aras\u0131nda ortalama fiyat hedefi 10,00 $ olmakla birlikte, son zorluklar nedeniyle genel g\u00f6r\u00fc\u015f \"Azalt\" y\u00f6n\u00fcnde de\u011fi\u015fti<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RXST\/forecast\/\">MarketBeat<\/a>.<\/p> <p><strong>2026 Projeksiyonu<\/strong>: 8,74 $<br\/> Yapay zeka tabanl\u0131 algoritmik tahminler, \u015firket mevcut zorluklar\u0131 a\u015farken \u0131l\u0131ml\u0131 bir toparlanma potansiyeli \u00f6ng\u00f6r\u00fcyor<a href=\"https:\/\/altindex.com\/ticker\/rxst\/price-prediction\">AltIndex<\/a>.<\/p> <p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 12-15 $ (spek\u00fclatif)<br\/> RxSight benimseme zorluklar\u0131n\u0131 a\u015fabilir ve piyasa g\u00fcvenini yeniden kazanabilirse uzun vadeli toparlanma potansiyeli.<\/p> <p><strong>2030 Vizyonu<\/strong>: 19,06 $<br\/> Uzun vadeli algoritmik projeksiyonlar, on y\u0131l i\u00e7inde \u00f6nemli b\u00fcy\u00fcme potansiyeli g\u00f6steriyor ancak bu t\u00fcr uzak tahminler y\u00fcksek belirsizlik i\u00e7eriyor<a href=\"https:\/\/altindex.com\/ticker\/rxst\/price-prediction\">AltIndex<\/a>.<\/p> <p><strong>Sonu\u00e7<\/strong>: Mevcut yasal zorluklar ve operasyonel engeller g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, RXST istikrarl\u0131 bir yat\u0131r\u0131mdan \u00e7ok <strong>y\u00fcksek riskli spek\u00fclatif bir oyun<\/strong> olarak de\u011ferlendirilmeli. Yaln\u0131zca risk sermayeniz varsa d\u00fc\u015f\u00fcn\u00fcn.<\/p>  <h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Yasal zorluklar<\/strong>: Kas\u0131m 2024 ile Temmuz 2025 aras\u0131nda menkul k\u0131ymet doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 iddialar\u0131 i\u00e7eren \u00e7oklu toplu dava<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/27\/3140337\/0\/en\/RXST-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-RxSight-Inc-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit.html\">Bronstein Law<\/a><\/li> <li><strong>Benimseme zorluklar\u0131<\/strong>: Y\u00f6netim, sat\u0131\u015f ve kullan\u0131mda d\u00fc\u015f\u00fc\u015fe neden olan \"yap\u0131sal sorunlar\u0131\" kabul etti<\/li> <li><strong>Mali istikrars\u0131zl\u0131k<\/strong>: 147M $ gelirine ra\u011fmen son 12 ayda 32,25 milyon $ zarar<a href=\"https:\/\/simplywall.st\/stocks\/us\/healthcare\/nasdaq-rxst\/rxsight\">Simply Wall St<\/a><\/li> <li><strong>Liderlik belirsizli\u011fi<\/strong>: Kritik d\u00f6nemde CFO'nun istifas\u0131 istikrars\u0131zl\u0131\u011f\u0131 art\u0131r\u0131yor<\/li> <\/ul> <h3>Toparlanma \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>E\u015fsiz teknoloji<\/strong>: D\u00fcnyada tek ameliyat sonras\u0131 ayarlanabilir intraok\u00fcler lens sistemi<\/li> <li><strong>Pazar b\u00fcy\u00fcmesi<\/strong>: 2025'te 8,90 milyar $ de\u011ferinde k\u00fcresel katarakt cerrahisi cihazlar\u0131 pazar\u0131, %4,27 CAGR ile b\u00fcy\u00fcyor<a href=\"https:\/\/www.ainvest.com\/news\/rxsight-strategic-position-evolving-cataract-surgery-market-deep-dive-innovation-investment-potential-2508\/\">AInvest<\/a><\/li> <li><strong>Kurulu taban b\u00fcy\u00fcmesi<\/strong>: Gelir zorluklar\u0131na ra\u011fmen LDD kurulumlar\u0131nda %34 art\u0131\u015f<\/li> <li><strong>G\u00fc\u00e7l\u00fc likidite<\/strong>: 12,68 cari oran finansal esneklik sa\u011fl\u0131yor<\/li> <\/ul>  <h2>\ud83c\udfdb\ufe0f Son 6 Ay\u0131n \u00d6nemli Haberleri<\/h2> <p>En dramatik geli\u015fme, RxSight'\u0131n Temmuz 2025 kazan\u00e7 raporu sonras\u0131 ortaya \u00e7\u0131kan <strong>menkul k\u0131ymet doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 toplu dava<\/strong> s\u00fcreci oldu. <a href=\"https:\/\/www.rgrdlaw.com\/cases-rxsight-inc-class-action-lawsuit-rxst.html\">Robbins Geller<\/a> ve <a href=\"https:\/\/rosenlegal.com\/case\/rxsight-inc\/\">Rosen Legal<\/a> gibi \u00e7ok say\u0131da hukuk firmas\u0131, \u00f6nemli kay\u0131plar ya\u015fayan yat\u0131r\u0131mc\u0131lar\u0131 temsil ediyor.<\/p> <p>Dava, toplu d\u00f6nem boyunca (7 Kas\u0131m 2024 - 8 Temmuz 2025) RxSight y\u00f6netiminin i\u015f performans\u0131 hakk\u0131nda maddi olarak yanl\u0131\u015f beyanlarda bulundu\u011funu ve k\u00f6t\u00fcle\u015fen ko\u015fullar hakk\u0131nda kritik bilgileri a\u00e7\u0131klamad\u0131\u011f\u0131n\u0131 iddia ediyor. \u015eikayet, RxSight'\u0131n Light Adjustable Lens \u00fcr\u00fcnlerine olan talebin abart\u0131lmas\u0131 ve benimseme zorluklar\u0131n\u0131n \u00f6nceki finansal rehberli\u011fi ula\u015f\u0131lmaz k\u0131lmas\u0131 nedeniyle a\u00e7\u0131klanmamas\u0131 konular\u0131n\u0131 \u00f6zellikle vurguluyor.<\/p> <p><strong>T\u00fcccarlar \u0130\u00e7in Pratik De\u011fer<\/strong>: Bu durum, b\u00fcy\u00fcme hisselerinde duyarl\u0131l\u0131\u011f\u0131n ne kadar h\u0131zl\u0131 de\u011fi\u015febilece\u011fini g\u00f6steriyor ve \u00e7e\u015fitlendirmenin \u00f6nemini vurguluyor. 22 Eyl\u00fcl 2025 lider davac\u0131 ba\u015fvurular\u0131 i\u00e7in son tarih, k\u0131sa vadede ek belirsizlik yarat\u0131yor.<\/p>  <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>A\u00e7\u0131kl\u0131k bekleyin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 ve yasal geli\u015fmeler netle\u015fene kadar giri\u015f yapmay\u0131n<\/li> <li><strong>K\u00fc\u00e7\u00fck pozisyon boyutlar\u0131<\/strong>: Yat\u0131r\u0131m yaparsan\u0131z, a\u015f\u0131r\u0131 volatilite nedeniyle portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2'si ile s\u0131n\u0131rlay\u0131n<\/li> <li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong>: Daha fazla d\u00fc\u015f\u00fc\u015fe kar\u015f\u0131 koruma i\u00e7in s\u0131k\u0131 risk y\u00f6netimi uygulay\u0131n<\/li> <li><strong>Esprili yakla\u015f\u0131m<\/strong>: \"\u015eu anda RXST ticareti yapmak, uygun e\u011fitim olmadan katarakt ameliyat\u0131 yapmak gibidir\u2014sonunda daha net g\u00f6rebilirsiniz ama prosed\u00fcr \u00f6nce ac\u0131 verici olabilir!\"<\/li> <\/ol>  <h2>\u2705 RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Uyumluluk i\u00e7in gerekli kimlik belgelerini sa\u011flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Banka hesab\u0131n\u0131zdan para transfer edin (k\u00fc\u00e7\u00fck ba\u015flay\u0131n)<\/td><\/tr> <tr><td>4<\/td><td>RXST'yi detayl\u0131 ara\u015ft\u0131r\u0131n<\/td><td>\u015eirketin zorluklar\u0131n\u0131 ve f\u0131rsatlar\u0131n\u0131 anlay\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Limit emirleri kullan\u0131n<\/td><td>Volatil ko\u015fullarda fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131 belirleyin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu yak\u0131ndan takip edin<\/td><td>Y\u00fcksek volatilite nedeniyle d\u00fczenli izleme \u015fartt\u0131r<\/td><\/tr> <tr><td>7<\/td><td>Risk y\u00f6netimi uygulay\u0131n<\/td><td>Daha fazla d\u00fc\u015f\u00fc\u015fe kar\u015f\u0131 stop-loss emirleri koyun<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>RXST gibi spek\u00fclatif pozisyonlar\u0131 d\u00fc\u015f\u00fcnenler i\u00e7in Pocket Option, yeni ba\u015flayanlara birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum depozito tutar\u0131 5 $<\/strong> \u2014 stratejileri minimal riskle test etmeye olanak tan\u0131r<\/li> <li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> \u2014 tek bir belge y\u00fckleyip hemen ticarete ba\u015flayabilirsiniz<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 kripto, e-c\u00fczdan veya banka kartlar\u0131yla kar eri\u015fiminde esneklik<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, y\u00fcksek volatiliteye sahip hisselere \u00f6nemli sermaye yat\u0131rmadan pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ve risk y\u00f6netimi \u00f6\u011frenmek i\u00e7in idealdir.<\/p>  <h2>\ud83c\udf0d 2025'te RxSight: Zorluklar Aras\u0131nda Yenilik<\/h2> <p>RxSight Inc., devrim niteli\u011findeki Light Adjustable Lens (LAL) teknolojisiyle katarakt cerrahisini de\u011fi\u015ftiren ticari a\u015famadaki bir t\u0131bbi teknoloji \u015firketidir<a href=\"https:\/\/stockanalysis.com\/stocks\/rxst\/company\/\">StockAnalysis<\/a>. \u015eirketin benzersiz sistemi, cerrahlar\u0131n ameliyat sonras\u0131 lens re\u00e7etelerini invaziv olmayan \u0131\u015f\u0131k tedavileriyle \u00f6zelle\u015ftirmesine olanak tan\u0131r\u2014d\u00fcnyada ba\u015fka hi\u00e7bir \u015firket b\u00f6yle bir hizmet sunmamaktad\u0131r.<\/p> <p>Mevcut zorluklara ra\u011fmen, RxSight <strong>Light Delivery Devices kurulu taban\u0131nda %34 b\u00fcy\u00fcme<\/strong> kaydetmekte ve 2030'a kadar 10,97 milyar $'a ula\u015fmas\u0131 beklenen k\u00fcresel katarakt cerrahisi pazar\u0131nda faaliyet g\u00f6stermektedir<a href=\"https:\/\/www.ainvest.com\/news\/rxsight-strategic-position-evolving-cataract-surgery-market-deep-dive-innovation-investment-potential-2508\/\">AInvest<\/a>.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Hisse \u00e7\u00f6k\u00fc\u015f\u00fcne ra\u011fmen, RxSight teknolojisi ge\u00e7en y\u0131la g\u00f6re %34 daha fazla klinik lokasyonda kullan\u0131lmaya devam ediyor; bu da ger\u00e7ek d\u00fcnya benimsemesinin yat\u0131r\u0131mc\u0131 duyarl\u0131l\u0131\u011f\u0131 k\u00f6t\u00fcle\u015fse bile s\u00fcrd\u00fc\u011f\u00fcn\u00fc g\u00f6steriyor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 RxSight Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla, RxSight, Inc. (RXST) NASDAQ borsas\u0131nda <strong>8,61 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Bu fiyat, y\u0131l\u0131n ba\u015f\u0131ndan bu yana dramatik bir d\u00fc\u015f\u00fc\u015f\u00fc temsil ediyor ve bu durum hem riskler hem de f\u0131rsatlar yarat\u0131yor.<\/p>\n<p><strong>Takviminize Not Edin: 6 Kas\u0131m 2025<\/strong>, RXST yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in son derece \u00f6nemli bir tarih. \u015eirketin bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 bu tarih, son d\u00f6nem performans g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 RXST Hissesini Nas\u0131l Etkiledi<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>7 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>7,95 $<\/td>\n<td>-%37,8 (y\u0131k\u0131c\u0131 rehberlik kesintisi)<\/td>\n<\/tr>\n<tr>\n<td>8 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>35,20 $<\/td>\n<td>+%3,2 (beklentileri a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>27 \u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>32,80 $<\/td>\n<td>+%7,3 (g\u00fc\u00e7l\u00fc g\u00f6r\u00fcn\u00fcm)<\/td>\n<\/tr>\n<tr>\n<td>7 Kas 2024<\/td>\n<td>\u00dcr\u00fcn G\u00fcncellemesi<\/td>\n<td>30,10 $<\/td>\n<td>+%5,1 (pozitif benimseme haberi)<\/td>\n<\/tr>\n<tr>\n<td>8 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>28,50 $<\/td>\n<td>-%4,2 (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td>\n<\/tr>\n<tr>\n<td>9 May 2024<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>29,80 $<\/td>\n<td>+%6,8 (g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Analizi<\/strong>: RxSight hissesi kazan\u00e7lar etraf\u0131nda a\u015f\u0131r\u0131 volatilite ya\u015fad\u0131; Temmuz 2025 \u00e7\u00f6k\u00fc\u015f\u00fc en \u015fiddetli tepkiyi temsil ediyor. Pozitif s\u00fcrprizler genellikle %5-7 kazan\u00e7 getirirken, olumsuz rehberlik kesintileri %30 veya daha fazla y\u0131k\u0131c\u0131 d\u00fc\u015f\u00fc\u015flere neden olabiliyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>RxSight hisseleri, t\u0131bbi teknoloji sekt\u00f6r\u00fcnde en dramatik \u00e7\u00f6k\u00fc\u015flerden birini ya\u015fad\u0131 ve bu d\u00f6nemde <strong>%75&#8217;ten fazla<\/strong> de\u011fer kaybetti:<\/p>\n<p><strong>\u015eubat<\/strong>: 35,20 $ (y\u0131la g\u00fc\u00e7l\u00fc ba\u015flang\u0131\u00e7)<br \/> <strong>Nisan<\/strong>: 32,50 $ (erken endi\u015feler ortaya \u00e7\u0131k\u0131yor)<br \/> <strong>Haziran<\/strong>: 28,80 $ (artan yat\u0131r\u0131mc\u0131 kayg\u0131s\u0131)<br \/> <strong>Temmuz<\/strong>: 7,95 $ (rehberlik kesintisi sonras\u0131 y\u0131k\u0131c\u0131 \u00e7\u00f6k\u00fc\u015f)<br \/> <strong>A\u011fustos<\/strong>: 8,61 $ (\u0131l\u0131ml\u0131 stabilizasyon)<\/p>\n<p>Bu y\u0131k\u0131c\u0131 d\u00fc\u015f\u00fc\u015f, RXST&#8217;nin Ocak 2025&#8217;te hisse ba\u015f\u0131na 35 $ \u00fczerinde i\u015flem g\u00f6rd\u00fc\u011f\u00fc g\u00fc\u00e7l\u00fc bir konumdan ba\u015flad\u0131; bu, 2024&#8217;te premium katarakt intraok\u00fcler lenslerdeki g\u00fc\u00e7l\u00fc performansla destekleniyordu. Ancak, 9 Temmuz 2025&#8217;te y\u00f6netimin tam y\u0131l gelir rehberli\u011fini kesmesi ve hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratan 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klamas\u0131yla hisseler g\u00fcn i\u00e7inde neredeyse <strong>%50<\/strong> \u00e7\u00f6k\u00fc\u015f ya\u015fad\u0131.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 8,00-10,00 $ \u2192 <strong>TUT<\/strong><br \/> Analistler, 11 firma aras\u0131nda ortalama fiyat hedefi 10,00 $ olmakla birlikte, son zorluklar nedeniyle genel g\u00f6r\u00fc\u015f &#8220;Azalt&#8221; y\u00f6n\u00fcnde de\u011fi\u015fti<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RXST\/forecast\/\">MarketBeat<\/a>.<\/p>\n<p><strong>2026 Projeksiyonu<\/strong>: 8,74 $<br \/> Yapay zeka tabanl\u0131 algoritmik tahminler, \u015firket mevcut zorluklar\u0131 a\u015farken \u0131l\u0131ml\u0131 bir toparlanma potansiyeli \u00f6ng\u00f6r\u00fcyor<a href=\"https:\/\/altindex.com\/ticker\/rxst\/price-prediction\">AltIndex<\/a>.<\/p>\n<p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 12-15 $ (spek\u00fclatif)<br \/> RxSight benimseme zorluklar\u0131n\u0131 a\u015fabilir ve piyasa g\u00fcvenini yeniden kazanabilirse uzun vadeli toparlanma potansiyeli.<\/p>\n<p><strong>2030 Vizyonu<\/strong>: 19,06 $<br \/> Uzun vadeli algoritmik projeksiyonlar, on y\u0131l i\u00e7inde \u00f6nemli b\u00fcy\u00fcme potansiyeli g\u00f6steriyor ancak bu t\u00fcr uzak tahminler y\u00fcksek belirsizlik i\u00e7eriyor<a href=\"https:\/\/altindex.com\/ticker\/rxst\/price-prediction\">AltIndex<\/a>.<\/p>\n<p><strong>Sonu\u00e7<\/strong>: Mevcut yasal zorluklar ve operasyonel engeller g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, RXST istikrarl\u0131 bir yat\u0131r\u0131mdan \u00e7ok <strong>y\u00fcksek riskli spek\u00fclatif bir oyun<\/strong> olarak de\u011ferlendirilmeli. Yaln\u0131zca risk sermayeniz varsa d\u00fc\u015f\u00fcn\u00fcn.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Yasal zorluklar<\/strong>: Kas\u0131m 2024 ile Temmuz 2025 aras\u0131nda menkul k\u0131ymet doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 iddialar\u0131 i\u00e7eren \u00e7oklu toplu dava<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/27\/3140337\/0\/en\/RXST-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-RxSight-Inc-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit.html\">Bronstein Law<\/a><\/li>\n<li><strong>Benimseme zorluklar\u0131<\/strong>: Y\u00f6netim, sat\u0131\u015f ve kullan\u0131mda d\u00fc\u015f\u00fc\u015fe neden olan &#8220;yap\u0131sal sorunlar\u0131&#8221; kabul etti<\/li>\n<li><strong>Mali istikrars\u0131zl\u0131k<\/strong>: 147M $ gelirine ra\u011fmen son 12 ayda 32,25 milyon $ zarar<a href=\"https:\/\/simplywall.st\/stocks\/us\/healthcare\/nasdaq-rxst\/rxsight\">Simply Wall St<\/a><\/li>\n<li><strong>Liderlik belirsizli\u011fi<\/strong>: Kritik d\u00f6nemde CFO&#8217;nun istifas\u0131 istikrars\u0131zl\u0131\u011f\u0131 art\u0131r\u0131yor<\/li>\n<\/ul>\n<h3>Toparlanma \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>E\u015fsiz teknoloji<\/strong>: D\u00fcnyada tek ameliyat sonras\u0131 ayarlanabilir intraok\u00fcler lens sistemi<\/li>\n<li><strong>Pazar b\u00fcy\u00fcmesi<\/strong>: 2025&#8217;te 8,90 milyar $ de\u011ferinde k\u00fcresel katarakt cerrahisi cihazlar\u0131 pazar\u0131, %4,27 CAGR ile b\u00fcy\u00fcyor<a href=\"https:\/\/www.ainvest.com\/news\/rxsight-strategic-position-evolving-cataract-surgery-market-deep-dive-innovation-investment-potential-2508\/\">AInvest<\/a><\/li>\n<li><strong>Kurulu taban b\u00fcy\u00fcmesi<\/strong>: Gelir zorluklar\u0131na ra\u011fmen LDD kurulumlar\u0131nda %34 art\u0131\u015f<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc likidite<\/strong>: 12,68 cari oran finansal esneklik sa\u011fl\u0131yor<\/li>\n<\/ul>\n<h2>\ud83c\udfdb\ufe0f Son 6 Ay\u0131n \u00d6nemli Haberleri<\/h2>\n<p>En dramatik geli\u015fme, RxSight&#8217;\u0131n Temmuz 2025 kazan\u00e7 raporu sonras\u0131 ortaya \u00e7\u0131kan <strong>menkul k\u0131ymet doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 toplu dava<\/strong> s\u00fcreci oldu. <a href=\"https:\/\/www.rgrdlaw.com\/cases-rxsight-inc-class-action-lawsuit-rxst.html\">Robbins Geller<\/a> ve <a href=\"https:\/\/rosenlegal.com\/case\/rxsight-inc\/\">Rosen Legal<\/a> gibi \u00e7ok say\u0131da hukuk firmas\u0131, \u00f6nemli kay\u0131plar ya\u015fayan yat\u0131r\u0131mc\u0131lar\u0131 temsil ediyor.<\/p>\n<p>Dava, toplu d\u00f6nem boyunca (7 Kas\u0131m 2024 &#8211; 8 Temmuz 2025) RxSight y\u00f6netiminin i\u015f performans\u0131 hakk\u0131nda maddi olarak yanl\u0131\u015f beyanlarda bulundu\u011funu ve k\u00f6t\u00fcle\u015fen ko\u015fullar hakk\u0131nda kritik bilgileri a\u00e7\u0131klamad\u0131\u011f\u0131n\u0131 iddia ediyor. \u015eikayet, RxSight&#8217;\u0131n Light Adjustable Lens \u00fcr\u00fcnlerine olan talebin abart\u0131lmas\u0131 ve benimseme zorluklar\u0131n\u0131n \u00f6nceki finansal rehberli\u011fi ula\u015f\u0131lmaz k\u0131lmas\u0131 nedeniyle a\u00e7\u0131klanmamas\u0131 konular\u0131n\u0131 \u00f6zellikle vurguluyor.<\/p>\n<p><strong>T\u00fcccarlar \u0130\u00e7in Pratik De\u011fer<\/strong>: Bu durum, b\u00fcy\u00fcme hisselerinde duyarl\u0131l\u0131\u011f\u0131n ne kadar h\u0131zl\u0131 de\u011fi\u015febilece\u011fini g\u00f6steriyor ve \u00e7e\u015fitlendirmenin \u00f6nemini vurguluyor. 22 Eyl\u00fcl 2025 lider davac\u0131 ba\u015fvurular\u0131 i\u00e7in son tarih, k\u0131sa vadede ek belirsizlik yarat\u0131yor.<\/p>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>A\u00e7\u0131kl\u0131k bekleyin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 ve yasal geli\u015fmeler netle\u015fene kadar giri\u015f yapmay\u0131n<\/li>\n<li><strong>K\u00fc\u00e7\u00fck pozisyon boyutlar\u0131<\/strong>: Yat\u0131r\u0131m yaparsan\u0131z, a\u015f\u0131r\u0131 volatilite nedeniyle portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2&#8217;si ile s\u0131n\u0131rlay\u0131n<\/li>\n<li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong>: Daha fazla d\u00fc\u015f\u00fc\u015fe kar\u015f\u0131 koruma i\u00e7in s\u0131k\u0131 risk y\u00f6netimi uygulay\u0131n<\/li>\n<li><strong>Esprili yakla\u015f\u0131m<\/strong>: &#8220;\u015eu anda RXST ticareti yapmak, uygun e\u011fitim olmadan katarakt ameliyat\u0131 yapmak gibidir\u2014sonunda daha net g\u00f6rebilirsiniz ama prosed\u00fcr \u00f6nce ac\u0131 verici olabilir!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Uyumluluk i\u00e7in gerekli kimlik belgelerini sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Banka hesab\u0131n\u0131zdan para transfer edin (k\u00fc\u00e7\u00fck ba\u015flay\u0131n)<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>RXST&#8217;yi detayl\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>\u015eirketin zorluklar\u0131n\u0131 ve f\u0131rsatlar\u0131n\u0131 anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Limit emirleri kullan\u0131n<\/td>\n<td>Volatil ko\u015fullarda fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu yak\u0131ndan takip edin<\/td>\n<td>Y\u00fcksek volatilite nedeniyle d\u00fczenli izleme \u015fartt\u0131r<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Risk y\u00f6netimi uygulay\u0131n<\/td>\n<td>Daha fazla d\u00fc\u015f\u00fc\u015fe kar\u015f\u0131 stop-loss emirleri koyun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>RXST gibi spek\u00fclatif pozisyonlar\u0131 d\u00fc\u015f\u00fcnenler i\u00e7in Pocket Option, yeni ba\u015flayanlara birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito tutar\u0131 5 $<\/strong> \u2014 stratejileri minimal riskle test etmeye olanak tan\u0131r<\/li>\n<li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> \u2014 tek bir belge y\u00fckleyip hemen ticarete ba\u015flayabilirsiniz<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 kripto, e-c\u00fczdan veya banka kartlar\u0131yla kar eri\u015fiminde esneklik<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, y\u00fcksek volatiliteye sahip hisselere \u00f6nemli sermaye yat\u0131rmadan pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ve risk y\u00f6netimi \u00f6\u011frenmek i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te RxSight: Zorluklar Aras\u0131nda Yenilik<\/h2>\n<p>RxSight Inc., devrim niteli\u011findeki Light Adjustable Lens (LAL) teknolojisiyle katarakt cerrahisini de\u011fi\u015ftiren ticari a\u015famadaki bir t\u0131bbi teknoloji \u015firketidir<a href=\"https:\/\/stockanalysis.com\/stocks\/rxst\/company\/\">StockAnalysis<\/a>. \u015eirketin benzersiz sistemi, cerrahlar\u0131n ameliyat sonras\u0131 lens re\u00e7etelerini invaziv olmayan \u0131\u015f\u0131k tedavileriyle \u00f6zelle\u015ftirmesine olanak tan\u0131r\u2014d\u00fcnyada ba\u015fka hi\u00e7bir \u015firket b\u00f6yle bir hizmet sunmamaktad\u0131r.<\/p>\n<p>Mevcut zorluklara ra\u011fmen, RxSight <strong>Light Delivery Devices kurulu taban\u0131nda %34 b\u00fcy\u00fcme<\/strong> kaydetmekte ve 2030&#8217;a kadar 10,97 milyar $&#8217;a ula\u015fmas\u0131 beklenen k\u00fcresel katarakt cerrahisi pazar\u0131nda faaliyet g\u00f6stermektedir<a href=\"https:\/\/www.ainvest.com\/news\/rxsight-strategic-position-evolving-cataract-surgery-market-deep-dive-innovation-investment-potential-2508\/\">AInvest<\/a>.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Hisse \u00e7\u00f6k\u00fc\u015f\u00fcne ra\u011fmen, RxSight teknolojisi ge\u00e7en y\u0131la g\u00f6re %34 daha fazla klinik lokasyonda kullan\u0131lmaya devam ediyor; bu da ger\u00e7ek d\u00fcnya benimsemesinin yat\u0131r\u0131mc\u0131 duyarl\u0131l\u0131\u011f\u0131 k\u00f6t\u00fcle\u015fse bile s\u00fcrd\u00fc\u011f\u00fcn\u00fc g\u00f6steriyor.<\/p>\n"},"faq":[{"question":"RxSight hisseleri nereden al\u0131nabilir?","answer":"RxSight hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden al\u0131m yapabilirsiniz."},{"question":"RxSight hisseleri i\u00e7in riskler nelerdir?","answer":"\u015eirketin kar\u015f\u0131 kar\u015f\u0131ya oldu\u011fu yasal davalar, benimseme zorluklar\u0131, mali istikrars\u0131zl\u0131k ve liderlik belirsizli\u011fi \u00f6nemli riskler aras\u0131ndad\u0131r."},{"question":"RxSight hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in fiyat tahmini 8,00-10,00 $ aral\u0131\u011f\u0131nda olup, uzun vadede 2030'a kadar 19,06 $ seviyelerine ula\u015fmas\u0131 beklenmektedir ancak y\u00fcksek belirsizlik vard\u0131r."},{"question":"Yeni ba\u015flayanlar RxSight hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Kazan\u00e7 raporlar\u0131 ve yasal geli\u015fmeler netle\u015fene kadar beklemek, k\u00fc\u00e7\u00fck pozisyonlar a\u00e7mak ve s\u0131k\u0131 stop-loss kullanmak \u00f6nerilir."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile yeni ba\u015flayanlar\u0131n risklerini y\u00f6neterek \u00f6\u011frenmelerine olanak tan\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"RxSight hisseleri nereden al\u0131nabilir?","answer":"RxSight hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden al\u0131m yapabilirsiniz."},{"question":"RxSight hisseleri i\u00e7in riskler nelerdir?","answer":"\u015eirketin kar\u015f\u0131 kar\u015f\u0131ya oldu\u011fu yasal davalar, benimseme zorluklar\u0131, mali istikrars\u0131zl\u0131k ve liderlik belirsizli\u011fi \u00f6nemli riskler aras\u0131ndad\u0131r."},{"question":"RxSight hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in fiyat tahmini 8,00-10,00 $ aral\u0131\u011f\u0131nda olup, uzun vadede 2030'a kadar 19,06 $ seviyelerine ula\u015fmas\u0131 beklenmektedir ancak y\u00fcksek belirsizlik vard\u0131r."},{"question":"Yeni ba\u015flayanlar RxSight hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Kazan\u00e7 raporlar\u0131 ve yasal geli\u015fmeler netle\u015fene kadar beklemek, k\u00fc\u00e7\u00fck pozisyonlar a\u00e7mak ve s\u0131k\u0131 stop-loss kullanmak \u00f6nerilir."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile yeni ba\u015flayanlar\u0131n risklerini y\u00f6neterek \u00f6\u011frenmelerine olanak tan\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r - RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r - RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T10:36:40+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T10:36:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/\",\"name\":\"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r - RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-28T10:36:40+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r - RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/","og_locale":"tr_TR","og_type":"article","og_title":"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r - RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T10:36:40+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T10:36:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/","name":"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r - RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-28T10:36:40+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-rxsight\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"RxSight, Inc. (RXST) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; RxSight, Inc. (RXST) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":354059,"slug":"how-to-buy-rxsight","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu RxSight, Inc. (RXST) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu RxSight, Inc. (RXST)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rxsight\/"},"pt_AA":{"locale":"pt_AA","id":354054,"slug":"how-to-buy-rxsight","post_title":"Como comprar a\u00e7\u00f5es da RxSight, Inc. (RXST) - Investimento em a\u00e7\u00f5es da RxSight, Inc. (RXST)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-rxsight\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=354055"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354055\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=354055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=354055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=354055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}